title: Response to: "hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer should be proposed in eight time points".
authors.affiliation: Hôpital Lyon Sud, Pierre Bénite, France; Université Lyon 1, EMR 3738, Lyon, France. Electronic address: olivier.glehen@chu-lyon.fr.
authors.forename: O
authors.initials: O
authors.lastname: Glehen
authors.affiliation: Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Department of Obstetrics and Gynaecology, Pierre Bénite, France; Université Lyon 1, EMR 3738, Lyon, France.
authors.forename: N
authors.initials: N
authors.lastname: Bakrin
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002277:Carcinoma / Q000188:drug therapy* / Q000601:surgery*; D010478:Chemotherapy, Cancer, Regional Perfusion; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000473:pathology*; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000601:surgery*
chemical_list: D000970:Antineoplastic Agents